| Trial ID: | L0189 |
| Source ID: | NCT04669158
|
| Associated Drug: |
Idebenone
|
| Title: |
Study of Oral Idebenone to Treat Non-Alcoholic Steatohepatitis
|
| Acronym: |
--
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non Alcoholic Steatohepatitis
|
| Interventions: |
Drug: Idebenone|Drug: Placebo
|
| Outcome Measures: |
Number of Participants with Treatment-Related Adverse Events as Assessed by CTCAE v4.0|Change in fibrosis stage
|
| Sponsor/Collaborators: |
Stanford University|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
|
| Gender: |
All
|
| Age: |
18 Years and older ?? (Adult, Older Adult)
|
| Phases: |
Phase 1/Phase 2
|
| Enrollment: |
45
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment
|
| Start Date: |
July 30, 2021
|
| Completion Date: |
March 2023
|
| Results First Posted: |
--
|
| Last Update Posted: |
July 23, 2021
|
| Locations: |
Digestive Health Center, Stanford University, Redwood City, California, United States|Stanford University, Stanford, California, United States
|
| URL: |
https://ClinicalTrials.gov/show/NCT04669158
|
